Pacific Biosciences of Ca... (PACB)
NASDAQ: PACB
· Real-Time Price · USD
1.29
0.06 (4.88%)
At close: Aug 15, 2025, 12:28 PM
Pacific Biosciences of California Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 156.11M | 152.36M | 154.01M | 173.15M | 188.87M | 200.43M | 200.52M | 169.52M | 146.14M | 134.03M | 128.3M | 136.97M | 139.55M | 134.69M | 130.51M | 121.63M | 105.83M | 92.29M |
Cost of Revenue | 484.78M | 489.77M | 116.73M | 136.35M | 144.18M | 146.13M | 147.74M | 121.17M | 102.14M | 89.39M | 79.27M | 76.31M | 77.07M | 74.65M | 71.65M | 68.14M | 60.63M | 54.24M |
Gross Profit | -328.67M | -337.41M | 37.28M | 36.8M | 44.69M | 54.3M | 52.78M | 48.35M | 43.99M | 44.64M | 49.03M | 60.66M | 62.48M | 60.04M | 58.86M | 53.49M | 45.2M | 38.05M |
Operating Income | -663.73M | -795.55M | -474.31M | -408.83M | -427.25M | -324.58M | -334.47M | -329.4M | -317.25M | -312.05M | -299.38M | -281.57M | -285.71M | -255.31M | -210.44M | -169.74M | -119.44M | -105.39M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.65M | 3.65M | 3.65M | 3.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -526.31M | -657.73M | -309.54M | -394.96M | -411.81M | -308.32M | -318.16M | -319.81M | -319.2M | -320.76M | -314.25M | -298.02M | -299.33M | -268.94M | -274.87M | -131.78M | -77.21M | -59.29M |
Net Income | -526.36M | -657.75M | -309.85M | -394.24M | -400.38M | -296.9M | -299.87M | -297.69M | -314.42M | -315.98M | -319.25M | -308.74M | -208.59M | -178.2M | -181.22M | -36.96M | -77.21M | -59.29M |
Selling & General & Admin | 161.24M | 160.78M | 163.02M | 167.87M | 167.55M | 172.41M | 169.82M | 168.82M | 162.19M | 160.87M | 160.85M | 153.17M | 147.98M | 137.79M | 124.13M | 104.76M | 87.92M | 73.99M |
Research & Development | 104.56M | 120.52M | 134.92M | 152M | 174M | 181.69M | 187.17M | 185.25M | 184.83M | 189M | 193M | 192.95M | 173.37M | 145.29M | 112.9M | 87.75M | 76.71M | 69.45M |
Other Expenses | 461.23M | 568.81M | 208.84M | 120.94M | 130.39M | 24.79M | 18M | 11.42M | 1.98M | 256K | -23K | -22K | -155K | -250K | 93K | 92K | 225K | 64K |
Operating Expenses | 727.03M | 850.11M | 506.78M | 440.81M | 471.94M | 378.88M | 374.99M | 365.5M | 348.99M | 349.87M | 353.85M | 346.12M | 321.35M | 283.08M | 237.02M | 192.5M | 164.63M | 143.44M |
Interest Expense | 9.77M | 11.57M | 13.41M | 14.23M | 14.28M | 14.29M | 14.34M | 14.42M | 14.5M | 14.62M | 14.69M | 14.52M | 14.53M | 14.44M | 12.53M | 9.05M | 5.38M | 1.79M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 846.17M | 974.24M | 628.33M | 581.98M | 616.12M | 525.01M | 522.73M | 486.67M | 451.13M | 439.26M | 433.12M | 422.43M | 398.42M | 357.73M | 308.68M | 260.64M | 225.26M | 197.68M |
Income Tax Expense | 49K | 14K | 316K | -718K | -11.42M | -11.42M | -18.29M | -22.12M | -4.78M | -5.11M | 4.67M | 10.39M | -91.07M | -90.74M | -94.19M | -95.37M | -543K | -543K |
Shares Outstanding (Basic) | 300.16M | 296.86M | 283M | 272.92M | 272.38M | 269.58M | 264.86M | 255M | 249.4M | 242.03M | 226.24M | 225.12M | 224.5M | 220.27M | 217.08M | 202.19M | 195.24M | 194.3M |
Shares Outstanding (Diluted) | 300.16M | 296.86M | 306.89M | 272.92M | 272.38M | 269.58M | 267.12M | 255M | 250.07M | 242.03M | 226.24M | 225.12M | 224.5M | 222.29M | 220.73M | 215.13M | 198.57M | 194.79M |
EPS (Basic) | -1.79 | -2.29 | -1.14 | -1.46 | -1.5 | -1.14 | -1.19 | -1.23 | -1.34 | -1.38 | -1.42 | -1.39 | -0.94 | -0.83 | -0.9 | -0.18 | -0.4 | -0.34 |
EPS (Diluted) | -1.79 | -2.29 | -1.14 | -1.46 | -1.5 | -1.14 | -1.19 | -1.23 | -1.34 | -1.38 | -1.42 | -1.38 | -0.93 | -0.82 | -0.89 | -0.21 | -0.43 | -0.37 |
EBITDA | -112.13M | -232.04M | -242.77M | -320.47M | -347.92M | -253.84M | -271.13M | -285.83M | -286.29M | -288.32M | -282.06M | -266.64M | -269.54M | -241.12M | -250.76M | -112.88M | -62.38M | -48.17M |
EBIT | -516.54M | -646.16M | -296.12M | -380.73M | -397.53M | -294.03M | -303.82M | -304.93M | -304.25M | -305.68M | -299.25M | -283.65M | -284.95M | -254.65M | -262.34M | -122.73M | -71.83M | -57.51M |
Depreciation & Amortization | 404.41M | 414.12M | 53.35M | 60.26M | 49.61M | 40.19M | 32.69M | 19.38M | 18.24M | 17.64M | 17.32M | 16.86M | 15.26M | 13.38M | 11.59M | 9.85M | 9.46M | 9.33M |